AGTC Joins the My Retina Tracker Program as a New Scientific Collaborator
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announced... Read More
Using HSV Helper Viruses to Increase AAV Production
Recognizing the industry-wide need to improve adeno-associated virus (AAV) vector manufacturing, UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation... Read More
Customized Gene Therapies Successfully Target Rare Eye Diseases
Can gene therapies be effective for the treatment of rare genetic diseases? One company may have found a solution that incorporates a... Read More
AGTC Formalizes Patient Advisory Council to Provide Insights and Guidance on Patient Perspectives for Pipeline Therapies
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company focused on developing adeno-associated... Read More
AGTC Announces Updated Development Plan for Its X-Linked Retinitis Pigmentosa Clinical Program
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials... Read More
AGTC Boosts AAV Manufacturing Productivity With Herpes Simplex Virus
By using the herpes simplex virus (HSV) as a helper for its adeno-associated viral (AAV) platform UF startup and UF Innovate |... Read More
AGTC Announces Significant Productivity and Quality Enhancement to Its Proprietary Manufacturing Process
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials... Read More
AGTC Launches Nationwide Mobile Vision Testing Program for Patients Enrolled in Its Ongoing Phase 1/2 Clinical Trials
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials... Read More
Otonomy and AGTC Present Preclinical Results for Gene Therapy Hearing Loss Program
Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, announced preclinical results from the company’s gene therapy... Read More
Foundation Park Building Sells for $12M
Avison Young real estate services announced the sale of a $12 million, newly-constructed 43,180-square-foot biotech and life science research facility at Foundation... Read More
